Concepedia

Schedule‐dependent Efficacy of Camptothecins in Models of Human Cancer<sup>a</sup>

Peter J. Houghton, Clinton F. Stewart, William C. Zamboni, Joyce Thompson, X Luo, Mary K. Danks, Janet A. Houghton

Annals of the New York Academy of Sciences · 1996 · 44 citations · 26 references

DOI

Concepts

References

26

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples

Richard Peto, M. C. Pike, P. Armitage et al. · British Journal of Cancer · 1977 · 8.4K citations · Full text

, , +13

Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy

Philippe E. Spiess, Andrew K. Lee, Dan Leibovici et al. · Cancer · 2006 · 1.9K citations

, , +17

CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer.

N Masuda, M. Fukuoka, Y Kusunoki et al. · Journal of Clinical Oncology · 1992 · 452 citations

, , +8

A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer.

M. Fukuoka, H Niitani, Atsushi Suzuki et al. · Journal of Clinical Oncology · 1992 · 435 citations

, , +16

Antitumor activity of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothec in, a novel water-soluble derivative of camptothecin, against murine tumors.

Takehiko Kunimoto, Kazuo Nitta, Takashi Tanaka et al. · PubMed · 1987 · 412 citations

, , +15